CN117327839A - PCR-HRM detection method for porcine epidemic diarrhea virus vaccine strain and wild strain - Google Patents
PCR-HRM detection method for porcine epidemic diarrhea virus vaccine strain and wild strain Download PDFInfo
- Publication number
- CN117327839A CN117327839A CN202311145046.8A CN202311145046A CN117327839A CN 117327839 A CN117327839 A CN 117327839A CN 202311145046 A CN202311145046 A CN 202311145046A CN 117327839 A CN117327839 A CN 117327839A
- Authority
- CN
- China
- Prior art keywords
- strain
- pcr
- epidemic diarrhea
- porcine epidemic
- diarrhea virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 title claims abstract description 44
- 238000001514 detection method Methods 0.000 title claims abstract description 41
- 229960005486 vaccine Drugs 0.000 title claims abstract description 29
- 238000002844 melting Methods 0.000 claims abstract description 16
- 230000008018 melting Effects 0.000 claims abstract description 16
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims description 45
- 238000006243 chemical reaction Methods 0.000 claims description 30
- 238000000137 annealing Methods 0.000 claims description 12
- 238000004925 denaturation Methods 0.000 claims description 7
- 230000036425 denaturation Effects 0.000 claims description 7
- 239000002773 nucleotide Substances 0.000 claims description 7
- 125000003729 nucleotide group Chemical group 0.000 claims description 7
- 238000012257 pre-denaturation Methods 0.000 claims description 7
- 230000003321 amplification Effects 0.000 claims description 6
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 2
- 239000013558 reference substance Substances 0.000 claims 2
- 241000700605 Viruses Species 0.000 abstract description 7
- 238000013461 design Methods 0.000 abstract description 4
- 230000035945 sensitivity Effects 0.000 abstract description 4
- 239000000523 sample Substances 0.000 description 9
- 238000003753 real-time PCR Methods 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 241000282898 Sus scrofa Species 0.000 description 4
- 238000012795 verification Methods 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000001650 pulsed electrochemical detection Methods 0.000 description 3
- 241000711573 Coronaviridae Species 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003748 differential diagnosis Methods 0.000 description 2
- 238000011841 epidemiological investigation Methods 0.000 description 2
- 238000003205 genotyping method Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000011880 melting curve analysis Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 101000768957 Acholeplasma phage L2 Uncharacterized 37.2 kDa protein Proteins 0.000 description 1
- 101000823746 Acidianus ambivalens Uncharacterized 17.7 kDa protein in bps2 3'region Proteins 0.000 description 1
- 101000916369 Acidianus ambivalens Uncharacterized protein in sor 5'region Proteins 0.000 description 1
- 101000769342 Acinetobacter guillouiae Uncharacterized protein in rpoN-murA intergenic region Proteins 0.000 description 1
- 101000823696 Actinobacillus pleuropneumoniae Uncharacterized glycosyltransferase in aroQ 3'region Proteins 0.000 description 1
- 101000786513 Agrobacterium tumefaciens (strain 15955) Uncharacterized protein outside the virF region Proteins 0.000 description 1
- 101000618005 Alkalihalobacillus pseudofirmus (strain ATCC BAA-2126 / JCM 17055 / OF4) Uncharacterized protein BpOF4_00885 Proteins 0.000 description 1
- 101000967489 Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB 13405 / ORS 571) Uncharacterized protein AZC_3924 Proteins 0.000 description 1
- 101000823761 Bacillus licheniformis Uncharacterized 9.4 kDa protein in flaL 3'region Proteins 0.000 description 1
- 101000819719 Bacillus methanolicus Uncharacterized N-acetyltransferase in lysA 3'region Proteins 0.000 description 1
- 101000789586 Bacillus subtilis (strain 168) UPF0702 transmembrane protein YkjA Proteins 0.000 description 1
- 101000792624 Bacillus subtilis (strain 168) Uncharacterized protein YbxH Proteins 0.000 description 1
- 101000790792 Bacillus subtilis (strain 168) Uncharacterized protein YckC Proteins 0.000 description 1
- 101000819705 Bacillus subtilis (strain 168) Uncharacterized protein YlxR Proteins 0.000 description 1
- 101000948218 Bacillus subtilis (strain 168) Uncharacterized protein YtxJ Proteins 0.000 description 1
- 101000718627 Bacillus thuringiensis subsp. kurstaki Putative RNA polymerase sigma-G factor Proteins 0.000 description 1
- 101000641200 Bombyx mori densovirus Putative non-structural protein Proteins 0.000 description 1
- 101000947633 Claviceps purpurea Uncharacterized 13.8 kDa protein Proteins 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 208000005156 Dehydration Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 101000948901 Enterobacteria phage T4 Uncharacterized 16.0 kDa protein in segB-ipI intergenic region Proteins 0.000 description 1
- 101710091045 Envelope protein Proteins 0.000 description 1
- 101000805958 Equine herpesvirus 4 (strain 1942) Virion protein US10 homolog Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101000790442 Escherichia coli Insertion element IS2 uncharacterized 11.1 kDa protein Proteins 0.000 description 1
- 101000788354 Escherichia phage P2 Uncharacterized 8.2 kDa protein in gpA 5'region Proteins 0.000 description 1
- 101710145505 Fiber protein Proteins 0.000 description 1
- 101000770304 Frankia alni UPF0460 protein in nifX-nifW intergenic region Proteins 0.000 description 1
- 101000797344 Geobacillus stearothermophilus Putative tRNA (cytidine(34)-2'-O)-methyltransferase Proteins 0.000 description 1
- 101000748410 Geobacillus stearothermophilus Uncharacterized protein in fumA 3'region Proteins 0.000 description 1
- 101000772675 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) UPF0438 protein HI_0847 Proteins 0.000 description 1
- 101000631019 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Uncharacterized protein HI_0350 Proteins 0.000 description 1
- 101000768938 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 8.9 kDa protein in int-C1 intergenic region Proteins 0.000 description 1
- 101000785414 Homo sapiens Ankyrin repeat, SAM and basic leucine zipper domain-containing protein 1 Proteins 0.000 description 1
- 101000833492 Homo sapiens Jouberin Proteins 0.000 description 1
- 101000651236 Homo sapiens NCK-interacting protein with SH3 domain Proteins 0.000 description 1
- 102100024407 Jouberin Human genes 0.000 description 1
- 101000782488 Junonia coenia densovirus (isolate pBRJ/1990) Putative non-structural protein NS2 Proteins 0.000 description 1
- 101000811523 Klebsiella pneumoniae Uncharacterized 55.8 kDa protein in cps region Proteins 0.000 description 1
- 101000818409 Lactococcus lactis subsp. lactis Uncharacterized HTH-type transcriptional regulator in lacX 3'region Proteins 0.000 description 1
- 101000878851 Leptolyngbya boryana Putative Fe(2+) transport protein A Proteins 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101000758828 Methanosarcina barkeri (strain Fusaro / DSM 804) Uncharacterized protein Mbar_A1602 Proteins 0.000 description 1
- 101001122401 Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) Non-structural protein ORF3 Proteins 0.000 description 1
- 101001055788 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) Pentapeptide repeat protein MfpA Proteins 0.000 description 1
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
- 101150068419 ORF 1 gene Proteins 0.000 description 1
- 101000740670 Orgyia pseudotsugata multicapsid polyhedrosis virus Protein C42 Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 101000769182 Photorhabdus luminescens Uncharacterized protein in pnp 3'region Proteins 0.000 description 1
- 241001673669 Porcine circovirus 2 Species 0.000 description 1
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 1
- 101710188315 Protein X Proteins 0.000 description 1
- 101000961392 Pseudescherichia vulneris Uncharacterized 29.9 kDa protein in crtE 3'region Proteins 0.000 description 1
- 101000731030 Pseudomonas oleovorans Poly(3-hydroxyalkanoate) polymerase 2 Proteins 0.000 description 1
- 101001065485 Pseudomonas putida Probable fatty acid methyltransferase Proteins 0.000 description 1
- 101000711023 Rhizobium leguminosarum bv. trifolii Uncharacterized protein in tfuA 3'region Proteins 0.000 description 1
- 101000948156 Rhodococcus erythropolis Uncharacterized 47.3 kDa protein in thcA 5'region Proteins 0.000 description 1
- 101000917565 Rhodococcus fascians Uncharacterized 33.6 kDa protein in fasciation locus Proteins 0.000 description 1
- 101150010882 S gene Proteins 0.000 description 1
- 101000790284 Saimiriine herpesvirus 2 (strain 488) Uncharacterized 9.5 kDa protein in DHFR 3'region Proteins 0.000 description 1
- 101000936719 Streptococcus gordonii Accessory Sec system protein Asp3 Proteins 0.000 description 1
- 101000788499 Streptomyces coelicolor Uncharacterized oxidoreductase in mprA 5'region Proteins 0.000 description 1
- 101001102841 Streptomyces griseus Purine nucleoside phosphorylase ORF3 Proteins 0.000 description 1
- 101000708557 Streptomyces lincolnensis Uncharacterized 17.2 kDa protein in melC2-rnhH intergenic region Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 102100021696 Syncytin-1 Human genes 0.000 description 1
- 101000649826 Thermotoga neapolitana Putative anti-sigma factor antagonist TM1081 homolog Proteins 0.000 description 1
- 241000711484 Transmissible gastroenteritis virus Species 0.000 description 1
- 101000827562 Vibrio alginolyticus Uncharacterized protein in proC 3'region Proteins 0.000 description 1
- 101000778915 Vibrio parahaemolyticus serotype O3:K6 (strain RIMD 2210633) Uncharacterized membrane protein VP2115 Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 208000011140 intestinal infectious disease Diseases 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses a PCR-HRM detection method for porcine epidemic diarrhea virus vaccine strain and wild strain, belonging to the technical field of virus detection. The invention designs a pair of novel detection primers for identifying porcine epidemic diarrhea virus vaccine strain and wild strain, wherein the upstream primers are as follows: TTGCGTAAGATGGCACAAC, the downstream primer is: ATAACAGTAT CACCAAGCCATAG. The primer is matched with a high-resolution melting curve technology, so that a high-throughput detection method with high specificity, good sensitivity and high accuracy is developed, and the primer can be used for identifying different strains of porcine epidemic diarrhea virus.
Description
Technical Field
The invention relates to a PCR-HRM detection method of porcine epidemic diarrhea virus vaccine strain and wild strain, belonging to the technical field of virus detection.
Background
Porcine epidemic diarrhea virus (Porcine Epidemic Diarrhea Virus, PEDV) belongs to the genus coronavirus of the family coronaviridae, and three proteins exist on the surface of the virion: membrane protein (M), fiber protein (S), envelope protein (E), and only nucleocapsid protein (N) within the virus, these several structural proteins are encoded by the ORF1 gene reading frame. PEDV is a virus commonly prevalent in swine herds and one of the viruses with higher detection positive rate. Porcine epidemic diarrhea (Porcine Epidemic Diarrhea, PED) is an acute, high-contact intestinal infectious disease which is caused by PEDV and takes diarrhea, vomiting and dehydration of piglets as main symptoms, pigs of various ages are susceptible, especially nursing piglets, the morbidity is up to 100%, and the mortality is 60-100%. Up to now, almost all provinces in China report the occurrence and popularity of PED, which seriously affects the healthy development of pig industry in China. The prevention and control of PEDs are mostly performed by vaccines, but there are also animals that fail to be immunized and are infected with PEDV wild strains at the same time as immunization is performed. The identification of the PEDV vaccine strain and the wild strain not only can evaluate whether the farm is infected by the wild strain, but also has important guiding significance for epidemiological investigation of the pig farm and formulation of vaccine immunization programs, and the cost is lower.
There are various methods for detecting PEDV, such as a colloidal gold method for detecting antigen and an ELISA method for detecting antibody, which are easy to operate, but cannot distinguish vaccine strains from wild strains, and an RT-PCR method for detecting nucleic acid, which is mainly based on the S gene or the auxiliary gene ORF3 for detecting PEDV, and the RT-PCR method is cumbersome to operate, takes a long time, can be uncapped back and forth in the detection process, is easy to cause pollution, and has high cost.
The high-resolution melting curve analysis technique (high-resolution melting, HRM) is a method for Single Nucleotide Polymorphism (SNP) and genotyping research, and is a simple, rapid and low-cost post-PCR amplification detection technique which can be used for high-throughput mutation scanning and genotyping. Although some HRM detection methods for identifying porcine epidemic diarrhea virus vaccine strain and wild strain are reported at present, detection sensitivity, specificity and accuracy still need to be further improved due to the problems of selection of different sites, design of primers and the like.
In view of this, the present invention has been made.
Disclosure of Invention
In order to solve the problems, the invention provides a novel porcine epidemic diarrhea virus vaccine strain and wild strain differential diagnosis detection method based on a high-resolution dissolution curve.
The first object of the invention is to provide a detection primer for porcine epidemic diarrhea virus, the nucleotide sequence of which is shown in SEQ ID NO. 5-6.
The second object of the invention is to provide a method for detecting porcine epidemic diarrhea virus vaccine strain and wild strain, which adopts a PCR-HRM reaction system comprising the detection primer to amplify and detect a sample containing porcine epidemic diarrhea virus.
Further, the amplification reaction procedure was: pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 10s, annealing at 52-65 ℃ for 10s, extension at 72 ℃ for 10s, and circulation for 40 times; 95℃60s,40℃60s,65℃1s,97℃1s.
Further, the annealing temperature is preferably 60 ℃.
Further, the PCR-HRM reaction system is as follows: green-2-Go2XqPCR-S Mastermix volume of 8-12. Mu.L, upstream and downstream primers of 0.2-0.4. Mu.L each, temp 1-3. Mu.L, ddH 2 O makes up 18-22. Mu.L.
Preferably, the PCR-HRM reaction system is: green-2-Go2XqPCR-S Mastermix volume of 10. Mu.L, upstream and downstream primers of 0.4. Mu.L each, temp 2. Mu.L, ddH 2 O makes up 20. Mu.L of the reaction system.
Further, the melting curve shows melting peaks at 81.7-81.9 ℃, and the PEDV wild strain is judged; the melting curve shows melting peaks at 82.3-82.5 ℃, and the PEDV vaccine strain is determined.
Further, melting curve analysis was performed at a melting rate of 0.07 ℃/s from 65 ℃ to 97 ℃.
The third object of the invention is to provide a kit for differential diagnosis and detection of porcine epidemic diarrhea virus vaccine strain and wild strain, which comprises: PCR-HRM reaction system containing the above detection primer.
Further, the kit also comprises a positive control substance or/and a negative control substance.
The kit can be used for detecting and identifying porcine epidemic diarrhea virus vaccine strains and wild strains.
The invention has the beneficial effects that:
the primer design is carried out aiming at the base difference of a plurality of sites of wild strains and vaccine strains, and a pair of primers capable of specifically amplifying target genes of the porcine epidemic diarrhea virus vaccine strains and the wild strains is obtained through screening, and the primers are different from target sequences aimed at in the existing detection method, so that the detection sensitivity and the detection accuracy are obviously improved. The PCR-HRM detection method based on the primer pair design has the advantages of low cost, simple operation, high detection speed, high flux, high accuracy, good specificity and good repeatability.
Drawings
FIG. 1 shows the detection limit results of vaccine strains and wild strains according to the invention.
FIG. 2 shows the result of the specific assay in example 5 of the present invention.
FIG. 3 shows qPCR detection results (Taqman method) of 30 clinical samples.
FIG. 4 shows the qPCR assay results (Taqman method) for 20 clinical samples.
FIG. 5 shows the HRM assay results of 30 clinical samples (invention).
Detailed Description
The present invention will be further described with reference to the accompanying drawings and specific examples, which are not intended to be limiting, so that those skilled in the art will better understand the invention and practice it.
The main reagents and material sources used in the following examples are shown in table 1:
table 1 reagent and manufacturer thereof
Example 1 primer screening
In this example, different primers were designed to compare and verify the specificity of the primers of the present invention. The comparison of the PEDV ORF1 sequences, the wild strain, compared with the vaccine strain, has the following characteristics, at 4405nt site g→a,4440nt, 4446nt, 9021nt, 9048nt site c→t,8994nt site c→a,9054nt site t→c. Based on the mutation characteristics, two pairs of primers were designed for screening (see table 2), and the reaction system: green-2-Go2XqPCR-S Mastermix volume of 10. Mu.L, upstream and downstream primers of 0.2. Mu.L each, temp 2. Mu.L, ddH 2 O makes up 20. Mu.L of the reaction system. The reaction procedure: pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 10s, annealing at 60 ℃ for 10s, extension at 72 ℃ for 10s, and circulation for 40 times; 95℃60s,40℃60s,65℃1s,97℃1s.
TABLE 2 primer information
Proved by verification, the ORF1-4400-F/R amplification fails, and the ORF1-9000-F1/R1 is successfully amplified and can be used for the establishment of a subsequent method. Wherein the nucleotide sequence of the recombinant plasmid CV777-ORF1-4400 is shown in SEQ ID NO.1, the nucleotide sequence of the recombinant plasmid CH-ORF1-4400 is shown in SEQ ID NO.2, the nucleotide sequence of the recombinant plasmid CV777-ORF1-9000 is shown in SEQ ID NO.3, and the nucleotide sequence of the recombinant plasmid CH-ORF1-9000 is shown in SEQ ID NO.4.
EXAMPLE 2 optimum Tm value screening
The annealing temperature is selected from 52-64.5 deg.c and the annealing temperature with relatively high delta Tm value. Amplifying target genes by adopting primers ORF1-9000-F1/R1, and adopting a reaction system: green-2-Go2XqPCR-SMastermix volumes were 10. Mu.L, and the upstream and downstream primers were 0.2. Mu.L each, temp 2. Mu.L, ddH 2 O makes up 20. Mu.L of the reaction system. Reaction processThe sequence is as follows: pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 10s, annealing at 52-64.5 ℃ for 10s, extension at 72 ℃ for 10s, and circulation for 40 times; 95℃60s,40℃60s,65℃1s,97℃1s. The results are shown in Table 3.
TABLE 3Tm results
Since the DeltaTm value is larger than 0 and is preferably larger, it can be seen from Table 3 that the DeltaTm value is at most 0.54, and the corresponding Tm value is 60℃and thus the annealing temperature of 52 to 64.5℃can be used for strain discrimination, and the optimum Tm value is 60 ℃.
Example 3 optimal addition amount screening of primers
The optimal addition amount of the primer is selected, the selection range is 0.2-0.4 uL, and the combination with higher delta Tm value is selected. The reaction system is as follows: 10. Mu.L Green-2-Go2XqPCR-S Mastermix, 2.0. Mu.L Temp, 0.2-0.4. Mu.L ORF1-9000-F1/R1, plus ddH 2 O was made up to 20. Mu.L. The reaction procedure is: pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 10s, annealing at 60 ℃ for 10s, extension at 72 ℃ for 10s, and circulation for 40 times; 95℃60s,40℃60s,65℃1s,97℃1s. The respective contents of the upstream primer and the downstream primer and the corresponding Δtm values are specifically shown in table 4.
TABLE 4 primer set results
Since the DeltaTm value is larger than 0 and is preferably larger, it can be seen from Table 4 that the highest DeltaTm value is 0.51 and the corresponding primer addition amount is 0.4. Mu.L, and therefore, primer addition amounts of 0.2 to 0.4. Mu.L/each can be used for strain discrimination, wherein the optimal primer addition amounts are each 0.4. Mu.L.
Example 4 sensitivity verification
1. Method of
(1) Extracting porcine epidemic diarrhea virus RNA in a sample by using a Tianlong nucleic acid extraction kit, wherein the sample can be intestinal tissue, anal swab, excrement and cell culture.
(2) Preparation of positive standard: constructing PEDV wild strain and vaccine strain positive standard, providing HRM positive control for detection of subsequent clinical samples, and diluting plasmid DNA to 10 7 The copies/. Mu.L served as positive control.
(3) The operation process comprises the following steps: the preparation reaction system is as follows: 10. Mu.L Green-2-Go2XqPCR-SMasermix, 2.0. Mu.L Temp, 0.4. Mu.L ORF1-9000-F1/R1, add ddH 2 O was made up to 20. Mu.L. The amplification procedure was set as follows: pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 10s, annealing at 60 ℃ for 10s, extension at 72 ℃ for 10s, and circulation for 40 times; detection was performed at 95℃for 60s,40℃for 60s,65℃for 1s, and 97℃for 1s.
(4) Analysis of results: the analysis process is carried out in a Rogowski fluorescence quantitative PCR instrument, and the instrument can complete the whole process of PCR-HRM analysis.
2. Results
(1) The result judgment criteria were: the melting curve shows melting peaks at 81.7-81.9 ℃, and the PEDV wild strain is judged; the melting curve shows melting peaks at 82.3-82.5 ℃, and the PEDV vaccine strain is determined.
(2) The minimum detection limit of the wild strain/vaccine strain is 5 copies/. Mu.L, see FIG. 1 (the purple area results are detectable, the red area results are undetectable).
(3) The CV values in the groups and between the groups are less than 1%, which shows that the method has good stability. See table below.
TABLE 5 results of repeatability verification
EXAMPLE 5 specific assay
The present example uses a variety of common viruses to perform specificity verification of the methods of the present invention. The viruses used in this example include: TGEV, poRV, PDCoV E.coli, APP, SS, CP, HPS, mhp, CSFV, PRRSV, PCV2, a wild strain of PEDV and a vaccine strain of PEDV. The results are shown in FIG. 2, and no melting curve appears for other pathogens except the PEDV wild strain and the PEDV vaccine strain, which shows that the method has good specificity.
Example 6 comparison of clinical sample detection Effect
30 samples of disease materials collected from Xinjiang scale pig farm are identified and detected, and the comparison is made between the PEDV identification fluorescent quantitative PCR detection method (Taqman probe method) and the method of the invention.
(1) PEDV species identification fluorescent quantitative PCR assay (Taqman)
The primers are shown in Table 6, the reaction system is shown in Table 7, and the amplification procedure is shown in Table 8.
TABLE 6 primer probe sequences (seed identification)
TABLE 7Taqman reaction System
TABLE 8Taqman amplification procedure
The results are shown in FIGS. 3-4. Of the 30 samples, 20 samples with positive detection results are further identified and detected for distinguishing PEDV wild strain from vaccine strain infection. The primer combinations of fluorescent quantitative PCR (Taqman) are shown in Table 9, the reaction system is shown in Table 7, and the reaction procedure is shown in Table 8.
TABLE 9 fluorescence quantitative PCR method primer information
Results 20 samples with positive detection results were wild strains.
(2) The method of the invention detects
The PCR-HRM method is adopted to directly carry out seed identification and parting detection on 30 clinical samples, the used primers are ORF1-9000-F1/R1, and the reaction system is as follows: green-The volume of 2-Go2XqPCR-S Mastermix was 10. Mu.L, each of the upstream and downstream primers was 0.4. Mu.L, temp 2. Mu.L, ddH 2 O makes up 20. Mu.L of the reaction system.
The reaction procedure is: pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 10s, annealing at 60 ℃ for 10s, extension at 72 ℃ for 10s, and circulation for 40 times; 95℃60s,40℃60s,65℃1s,97℃1s.
The results show (FIG. 5) that 20 samples were obtained as wild strains. Therefore, the method is consistent with the fluorescent quantitative PCR (Taqman) and the identification detection result, and the method can realize identification parting by one-time detection, and has shorter time and lower cost.
(3) Cost accounting contrast
Taking epidemiological investigation and detection sample numbers in Xinjiang as reference examples, 1000 cases are detected, the unit price of one sample detected and typed by the Taqman method is 20 yuan, the unit price of one sample by the HRM method is 3 yuan, the cost of detection and typing by the Taqman method is 4 ten thousand yuan, the cost of detection by the HRM method is 3 kiloyuan, and the cost is reduced by more than 10 times.
The above-described embodiments are merely preferred embodiments for fully explaining the present invention, and the scope of the present invention is not limited thereto. Equivalent substitutions and modifications will occur to those skilled in the art based on the present invention, and are intended to be within the scope of the present invention. The protection scope of the invention is subject to the claims.
Claims (10)
1. A detection primer for porcine epidemic diarrhea virus is characterized in that the nucleotide sequence is shown as SEQ ID NO. 5-6.
2. A method for detecting porcine epidemic diarrhea virus vaccine strain and wild strain, characterized in that a sample containing porcine epidemic diarrhea virus is amplified and detected by using a PCR-HRM reaction system comprising the detection primer of claim 1.
3. The method according to claim 2, wherein the reaction procedure for amplification using the PCR-HRM reaction system is: pre-denaturation at 95 ℃ for 3min, denaturation at 95 ℃ for 10s, annealing at 52-65 ℃ for 10s, extension at 72 ℃ for 10s, and circulation for 40 times; 95℃60s,40℃60s,65℃1s,97℃1s.
4. A method according to claim 3, wherein the annealing temperature in the reaction sequence is 60 ℃.
5. The method of claim 2, wherein the PCR-HRM reaction system is: green-2-Go2XqPCR-S Mastermix volume of 8-12. Mu.L, upstream and downstream primers of 0.2-0.4. Mu.L each, temp 1-3. Mu.L, ddH 2 O is added to the mixture to be 18-22 mu L; preferably, the PCR-HRM reaction system is: green-2-Go2XqPCR-S Mastermix volume of 10. Mu.L, upstream and downstream primers of 0.4. Mu.L each, temp 2. Mu.L, ddH 2 O makes up 20. Mu.L of the reaction system.
6. The method of claim 5, wherein each of the upstream and downstream primers is 0.4. Mu.L.
7. The method according to claim 2, characterized in that: the melting curve shows melting peaks at 81.7-81.9 ℃, and the PEDV wild strain is judged; the melting curve shows melting peaks at 82.3-82.5 ℃, and the PEDV vaccine strain is determined.
8. The kit for identifying, diagnosing and detecting the porcine epidemic diarrhea virus vaccine strain and wild strain is characterized by comprising the following components: a PCR-HRM reaction system comprising the detection primer of claim 1.
9. The kit of claim 8, wherein: the kit also comprises a positive reference substance or/and a negative reference substance.
10. Use of the kit according to claim 8 or 9 for detecting porcine epidemic diarrhea virus vaccine strain and wild strain.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311145046.8A CN117327839A (en) | 2023-09-06 | 2023-09-06 | PCR-HRM detection method for porcine epidemic diarrhea virus vaccine strain and wild strain |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311145046.8A CN117327839A (en) | 2023-09-06 | 2023-09-06 | PCR-HRM detection method for porcine epidemic diarrhea virus vaccine strain and wild strain |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117327839A true CN117327839A (en) | 2024-01-02 |
Family
ID=89281954
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311145046.8A Pending CN117327839A (en) | 2023-09-06 | 2023-09-06 | PCR-HRM detection method for porcine epidemic diarrhea virus vaccine strain and wild strain |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117327839A (en) |
-
2023
- 2023-09-06 CN CN202311145046.8A patent/CN117327839A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105624330B (en) | 12 boar common virus and bacterium Taqman-MGB PCR kit for fluorescence quantitative and method are detected simultaneously | |
CN110760620A (en) | Classical swine fever virus and African classical swine fever virus dual-fluorescence PCR detection reagent, kit and detection method | |
US20230203575A1 (en) | Novel coronavirus rapid detection kit based on thermal convection pcr | |
CN108866243B (en) | Porcine enterocoronavirus 4-fold fluorescent quantitative PCR detection kit | |
CN112795704B (en) | RAA primer pair, probe combination and kit for detecting porcine pseudorabies virus | |
CN113684309A (en) | 7 primer probe and kit for detecting viruses related to porcine reproductive disorder diseases based on liquid chip technology and application of primer probe and kit | |
CN111518955A (en) | HRM primer pair, kit and method for rapidly identifying feline enterocoronavirus and feline infectious peritonitis virus | |
CN105907890A (en) | Primers, probe and method for rapidly distinguishing HP-PRRS (High pathogenic porcine reproductive and respiratory syndrome) vaccine strain GDr180 from HP-PRRS wild strain | |
CN113718045B (en) | DNA fragment, primer, probe and kit for detecting 4 kinds of Bordetella pertussis and specifically detecting Bordetella pertussis and application | |
CN114350848B (en) | Dual fluorescent probe primer combination for identifying African swine fever type I strain and type II strain, kit and application thereof | |
CN113943831A (en) | Multiple fluorescent quantitative primer and probe combination capable of diagnosing three high-incidence pathogens of porcine diarrhea disease simultaneously and application thereof | |
CN111676316B (en) | Primer, probe and detection method for rapidly distinguishing African swine fever virus gene type II from other genotypes | |
CN116162734B (en) | Specific primer, probe and kit for rapidly detecting African swine fever wild strain and gene deletion strain | |
CN116004920B (en) | Fluorescence PCR detection method and kit for four different lineages of strains of porcine reproductive and respiratory syndrome | |
CN116814859A (en) | Primer probe composition, kit and method for identifying African swine fever virus genes I and II | |
CN116024208B (en) | Kit capable of simultaneously detecting 26 pig epidemic diseases through single reaction | |
CN114438265B (en) | Nucleic acid composition, kit and detection method for simultaneously detecting porcine delta coronavirus, reovirus and porcine kokumi virus | |
CN111471802A (en) | Porcine delta coronavirus rapid detection primer, kit and application thereof | |
CN111500767A (en) | Microfluid chip for simultaneously detecting 9 porcine pathogens | |
CN110804677A (en) | Nested duplex PCR (polymerase chain reaction) detection primer and kit for distinguishing African swine fever virus wild strain and gene deletion strain | |
CN113151586B (en) | Primer combination, kit and method for detecting and identifying porcine pseudorabies virus type I and type II | |
CN117327839A (en) | PCR-HRM detection method for porcine epidemic diarrhea virus vaccine strain and wild strain | |
CN109517929B (en) | Primer group and kit for porcine circovirus detection and type2 typing | |
CN111440902A (en) | Porcine epidemic diarrhea virus detection primer, kit and application thereof | |
CN114317835B (en) | Multiplex PCR detection primer set, kit and detection method for waterfowl parvovirus, duck enteritis virus and goose astrovirus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |